Nissha Acquires Sequel Special Products

Boston, Massachusetts – July 20, 2018 – Alira Health is pleased to announce its role as exclusive financial advisor to Sequel Special Products LLC in the sale to Nissha Co. Ltd.

Nissha Co. Ltd. acquired Sequel Special Products, LLC to expand its Medical Technologies segment. Sequel Special Products engages in contract manufacturing of medical devices, and its affiliated company, RSS Design, LLC, engages in the development and design of medical devices. The acquisition took place on June 25, 2018, through Graphic Controls Group, a Nissha subsidiary.

This acquisition will provide the Medical Technologies segment with new sales channels in contract manufacturing, increased production capacity, and expanded product development and design functions to improve its value chain from development to production to sales.

In 2016, Nissha introduced the Medical Technologies segment and achieved full-scale entry into the medical devices market with the acquisition of a subsidiary of U.S.-based medical devices manufacturer, Graphic Controls Group. Current offerings focus on medical electrodes, medical surgical devices, and other products for cardiology, which have strong synergies with Nissha’s core technologies of “Patterning”, “Coating”, “Lamination”, and “Molding”. Nissha provides these global contract manufacturing services for major medical device manufacturers and produces and distributes as a proprietary brand for hospitals.

ABOUT SEQUEL SPECIAL PRODUCTS LLC

Since 1994, Sequel Medical has been providing a full range of engineering and manufacturing services to medical device and life science companies. From early stage start-ups to large corporations, Sequel’s customers benefit from their creative approach to solving complex problems, sound engineering, and highly disciplined manufacturing processes. Sequel Medical is an FDA-registered and ISO13485- certified company. Sequel’s Quality Management System  (QMS) and stringent design and manufacturing processes are defined in full compliance with the FDA’s Quality System Regulations (QSR) and ISO requirements. Sequel uses advanced engineering and analytical tools and sophisticated test and manufacturing equipment to design, develop and manufacture safe and reliable medical products.

ABOUT NISSHA CO. LTD

Nissha Group, headquartered in Japan, is composed of four business segments of “Industrial Materials”, “Devices”, “Medical Technologies” and “Information and Communication”. Nissha introduced the Medical Technologies segment and achieved full-scale entry into the medical devices market in September 2016. Medical Technologies aims to extend capabilities such as product development and design, and enrich its lineup of distinctive products toward sustainable growth.

TO LEARN MORE, PLEASE CONTACT 

Aude Ouensanga

Project Manager, Boston

aude.ouensanga@alirahealth.com

 

Gabriele Brambilla

Chief Executive Officer, Boston

gabriele.brambilla@alirahealth.com

 

CONNECT WITH ALIRA HEALTH

To receive new information, thought-provoking whitepapers, and opportunities to connect with healthcare experts on everything from regulatory and clinical trial challenges to strategy and financing solutions, we invite you to join our email list.